BIOEN.E — Biotrend Cevre ve Enerji Yatirimlari AS Income Statement

0.000.00%

Last trade - 00:00

UtilitiesSpeculativeSmall CapNeutral

Market Cap
TRY9.52bn
Enterprise Value
TRY12.36bn
Revenue
TRY1.23bn

Annual income statement for Biotrend Cevre ve Enerji Yatirimlari AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	R2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	49.2	92.1	245	428	1,231
Cost of Revenue
Gross Profit	17.8	27.4	67.8	123	426
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	33.7	66.9	176	377	860
Operating Profit	15.5	25.1	69.3	50.9	371
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.566	6.43	59.4	23.4	197
Provision for Income Taxes
Net Income After Taxes	-1.46	2.75	49.9	4	311
Minority Interest
Net Income Before Extraordinary Items
Net Income	-1.21	5.68	50.5	6.54	311
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-1.21	5.68	50.5	6.54	311
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.002	0.009	0.106	0.07	0.635
Dividends per Share